C9orf72 and frontotemporal dementia: Lastly, in the small phase 2 single-site metformin trial of 18 participants for the most commonly known FTD genetic mutation (C9orf72), it is hypothesized that metformin may restore mitochondrial function by inhibiting abnormal dipeptide repeat proteins in the presence of ALS and FTD [43].